Eli Lilly, Merck top pharma picks in Barclays Q2 preview

Dmitry Dzhimidovich

As investors prepare for another challenging quarter when earnings season begins in the biopharmaceutical business later this month, Barclays has picked Eli Lilly (New York Stock Exchange: LLY) and Merck (New York Stock Exchange: MRK) as two of the best large companies

BarclaysEliLillyMerckPharmaPicksPreviewTop
Comments (0)
Add Comment